Clinical, Nutritional and Biochemical Consequences of Apolipoprotein B Deficiency

  • Herbert J. Kayden
  • Maret G. Traber
Part of the Advances in Experimetal Medicine and Biology book series (AEMB, volume 201)


Abetalipoproteinemia (ABL) was originally described 35 years ago (1) and to date approximately 100 patients have been recognized to have this inborn metabolic abnormality. We have continued to follow some 25 patients with the homozygous form of either ABL or hypobetalipoproteinemia. Our efforts are directed toward the clinical and biochemical evaluation of patients with particular stress on delineating changes in the neurological system, along with ocular changes, both retinopathy and opthalmoplegia. We have carefully documented the degree of neurological abnormality in these patients and have measured their adipose tissue levels of tocopherol (vitamin E). We have also continued to characterize the apolipoprotein and lipoprotein abnormalities in these patients. This report will stress a number of facets of the disease of ABL; these include published work of our own and others, and also reflect the work in progress in a number of areas, the most important of which is the recognition that the neurological abnormalities seen in ABL are a result of vitamin E deficiency and that these neurological abnormalities can be prevented by the oral administration of vitamin E from infancy and early childhood.


Lipoprotein Lipase Neurological Abnormality Tocopherol Content Familial Hypercholesterolemia Lipoprotein Lipase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bassen, F.A. and A.L. Kornzweig. (1950). Malformation of the erythro-cytes in a case of atypical retinitis pigmentosa. Blood 5:381–387.PubMedGoogle Scholar
  2. 2.
    Scanu, A.M., L.P. Aggerbeck, A.W. Kruski, C.T. Lira and H.J. Kayden. (1974). A study of the abnormal lipoproteins in abetalipoproteinemia. J. Clin. Invest. 53:440–453.CrossRefGoogle Scholar
  3. 3.
    Kostner, G., A. Holasek, H.G. Bohlmann and H. Thiede. (1974). Investigation of serum lipoproteins and apoproteins in abetalipoproteinaemia. Clin. Sci. and Mol. Med. 46:457–468.Google Scholar
  4. 4.
    Shepherd, J., M. Caslake, E. Farish and A. Fleck. (1978). Chemical and kinetic study of the lipoproteins in abetalipoproteinaemic plasma. J. Clin. Path. 31:382–387.Google Scholar
  5. 5.
    Cottrill, C., C.J. Glueck, V. Leuba, F. Millett, D. Puppione and W.V. Brown. (1974). Familial Homozygous Hypobetalipoproteinemia. Metabolism 23:779–791.PubMedCrossRefGoogle Scholar
  6. 6.
    Mars, H., L.A. Lewis, A.L. Robertson, A. Butkus and G.H. Williams. (1969). Familial hypobetalipoproteinemia. A genetic disorder of lipid metabolism with nervous system involvement. Am. J. Med. 46:886–900.CrossRefGoogle Scholar
  7. 7.
    Haga, P., J. Ek and S. Kran. (1982). Plasma tocopherol levels and vitamin E/beta lipoprotein relationships during pregnancy and in cord blood. Am. J. Clin. Nutr. 36:1200–1204.Google Scholar
  8. 8.
    Kayden, H.J. and R. Silber. (1965). The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis. Trans. Assoc. Am. Phys. 78:334–341.Google Scholar
  9. 9.
    Caballero, F.M. and G.R. Buchanan. (1980). Abetalipoproteinemia presenting as severe vitamin K deficiency. Pediatrics 65:161–163.PubMedGoogle Scholar
  10. 10.
    Illingworth, D.R., W.E. Connor and R.G. Miller. (1980). Abetalipoproteinemia; report of two cases and review of therapy. Arch. Neurol. 37:659–662.Google Scholar
  11. 11.
    Gouras, P., R.E. Carr and R.D. Gunkel. (1971). Retinitis pigmentosa in abetalipoproteinemia: Effects of vitamin A. Invest. Ophthal. 10:784–793.Google Scholar
  12. 12.
    Bishara, S., S. Merin, M. Cooper, E. Aziz, G. Delpre and R.J. Deckelbaum. (1971). Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoprotein-aemia. Brit. J. Ophthal. 12:767–770.Google Scholar
  13. 13.
    Bieri, J.G., J.M. Hoeg, E.J. Schaefer, L.A. Zech and B. Brewer. (1984). Vitamin A and vitamin E replacement in abetalipoproteinemia. Ann. Int. Med. 100:238–239.Google Scholar
  14. 14.
    Bjornson, L.K., H.J. Kayden, E. Miller and A.N. Moshell. (1976). The transport of alpha tocopherol and beta carotene in human blood. J. Lipid Res. 17:343–351.Google Scholar
  15. 15.
    Behrens, W.A., J.N. Thompson and R. Madere. (1982). Distribution of alpha tocopherol in human plasma lipoproteins. Ara. J. Clin. Nutr. 35:691–696.Google Scholar
  16. 16.
    Kayden, H.J. 1969. Vitamin E deficiency in patients with abetalipoproteinemia. Vitamine A, E und K. Klinische und physiologischchemische probleme-Symposiom September 1967. H.F. von Kress and K.U. Blum, editors, p 301-308.Google Scholar
  17. 17.
    Kayden, H.J. (1980). Is essential fatty acid deficiency part of the syndrome of abetalipoproteinemia? Nutr. Rev. 38:244–246.Google Scholar
  18. 18.
    Nelson, J.S. (1983). Neuropathological studies of chronic vitamin E deficiency in mammals including humans. R. Porter and J. Whelan, editors. Ciba Found. Symp. 101:92–99.PubMedGoogle Scholar
  19. 19.
    Brin, M.F. and M.G. Traber. 1985. Vitamin E deficiency and human neurological disease. Laboratory Management. In Press.Google Scholar
  20. 20.
    Brin, M.F., T.A. Pedley, R.G. Emerson, R.E. Lovelace, P. Gouras, C. MacKay, H.J. Kayden, J. Levy and Herman Baker. 1985. Electrophysiological features of abetalipoproteinemia: functional consequences of vitamin E deficiency. Neurology. Submitted.Google Scholar
  21. 21.
    Cogan, D.G., M. Rodrigues, F.C. Chu and E.J. Schaefer. (1984). Ocular abnormalities in abetalipoproteinemia. A clinicopathologic correlation. Ophthal. 91:991–998.Google Scholar
  22. 22.
    Brin, M.F., J.S. Nelson, W.C. Roberts, M.D. Marquardt, P. Suswankosai and C.K. Petito. (1983). Neuropathology of abetalipoproteinemia: A possbile complication of the tocopherol (vitamin E)-deficient state. Neurology 33(suppl 2):142–143.Google Scholar
  23. 23.
    Kayden, H.J., L.J. Hatam and M.G. Traber. (1983). The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: normal and abetalipoproteinemic subjects. J. Lipid Res. 24:652–656.Google Scholar
  24. 24.
    Kayden, H.J. (1983). Tocopherol content of adipose tissue from vitamin E-deficient humans. R. Porter and J. Whelan, editors. Ciba Found. Symp. 101:70–91.PubMedGoogle Scholar
  25. 25.
    Hegele, R.A. and A. Angel. (1985). Arrest of neuropathy and myopathy in abetalipoproteinemia with high dose vitamin E therapy. Can. Med. Assoc. J. 132:41–44.PubMedGoogle Scholar
  26. 26.
    Malloy, M.J., J.P. Kane, D.A. Hardman, R.L. Hamilton and K.B. Dalai. (1981). Normotriglyceridemic abetalipoproteinemia; absence of the B-100 apolipoprotein. J. Clin. Invest. 67:1441–1450.CrossRefGoogle Scholar
  27. 27.
    Muller, D.P.R., J.K. Lloyd and A.C. Bird. (1977). Long-term management of abetalipoproteinaemia; possible role for vitamin E. Arch. Dis. Child. 52:209–214.CrossRefGoogle Scholar
  28. 28.
    Lowry, N.J., M.J. Taylor, W. Belknapp and W.J. Logan. (1984). Electro-physiological studies in five cases of abetalipoproteinemia. Can. J. Neurol. Sci. 11:60–63.Google Scholar
  29. 29.
    Sperling, M.A., F. Hengstenberg, E. Yunis, F.M. Kenny and A.L. Drash. (1971). Abetalipoproteinemia: metabolic, endocrine and electron-microscopic investigations. Pediatrics 48:91–102.PubMedGoogle Scholar
  30. 30.
    Partin, J.S., J.C., Partin, W.K. Schubert, et al. (1974). Liver ultrastructure in abetalipoproteinemia: Evolution of micronodular cirrhosis. Gastroenterology 67:107–118.PubMedGoogle Scholar
  31. 31.
    Nelsson-Ehle, P., A.S. Garfinkel and M.C. Schotz. (1980). Lipolytic enzymes and plasma lipoprotein metabolism. Ann. Rev. Biochem. 49:667–693.CrossRefGoogle Scholar
  32. 32.
    Goldstein J.L. and M.S. Brow. (1976). The LDL pathway in human fibroblasts: a receptor mediated mechanism for the regulation of cholesterol metabolism. Curr. Top. in Cell Regul. 11:147–81.Google Scholar
  33. 33.
    Traber, M.G., T. Olivecrona and H.J. Kayden. (1985). Bovine milk lipoprotein lipase transfers tocopherol to human fibroblasts during triglyceride hydrolysis in vitro. J. Clin. Invest. 75:In Press.CrossRefGoogle Scholar
  34. 34.
    Traber, M.G. and H.J. Kayden. (1984). Vitamin E is delivered to cells via the high affinity receptor for low density lipoprotein. Am. J. Clin. Nutr. 40:747–751.Google Scholar
  35. 35.
    Chajek-Shaul, T., G. Friedman, O. Stein, T. Olivecrona and Y. Stein. (1982). Binding of lipoprotein lipase to the cell surface is essential for the transmembrane transport of chylomicron cholesteryl ester. Biochim. Biophys. Acta 712:200–210.Google Scholar
  36. 36.
    Kayden, H.J. and L.K. Bjornson. (1972). The dynamics of vitamin E transport in the human erythrocyte. Ann. N.Y. Acad. Sci. 203:127–140.Google Scholar
  37. 37.
    Kostner, G.M., H.G. Bohlmann and A. Holasek. (1976). The recycling of apolipoproteins between lipoproteins of different density classes in the serum of patients with apo B-deficiency after intravenous intralipid administration. J. Mol. Med. 1:311–324.CrossRefGoogle Scholar
  38. 38.
    Cooper, R.A. and C. L. Gulbrandsen. (1971). The relationship between serum lipoproteins and red cell membranes in abetalipoproteinemia: Deficiency of lecithinrcholesterol acyltransferase. J. Lab. Clin. Med. 78:323–335.Google Scholar
  39. 39.
    Subbaiah, P.V. (1982). Requirement of Low Density Lipoproteins for the Lysolecithin Acyl Transferase Activity in human plasma: assay of enzyme activity in abetalipoproteinemic patients. Metabolism 31:294–298.PubMedCrossRefGoogle Scholar
  40. 40.
    Kayden, H.J., L. Hatam and N.G. Beratis. (1976). Regulation of 3-hydroxy-3-methylglutaryl Coenzyme A reductase activity and the esterification of cholesterol in human long term lymphoid cell lines. Biochem. 15:521–528.CrossRefGoogle Scholar
  41. 41.
    Kayden, H.J. 1978. Abetalipoproteinemia: abnormalities of serum lipoproteins. Protides of the Biological Fluids. H. Peeters, Editor. Pergamon Press. p271-276.Google Scholar
  42. 42.
    Myant, N.B., D. Reichl and J.K. Lloyd. (1978). Sterol balance in a patient with abetalipoproteinaemia. Atherosclerosis 29:509–512.PubMedCrossRefGoogle Scholar
  43. 43.
    Illingworth, D.R., Connor, W.E., Buist, N.R., B.M. Jhaveri, D.S. Lin, and M.P. McMurry. (1979). Sterol Balance in Abetalipoproteinemia: Studies in a patient with homozygous familial hypobetalipopro-teinemia. Metabolism 28:1152–1160.PubMedCrossRefGoogle Scholar
  44. 44.
    Blum, C.B., Deckelbaum, R.J., Witte, L.D., Tall, A.R. and J. Cornicelli. (1982). Role of apolipoprotein E-containing lipoproteins in abetalipoproteinemia. J. Clin. Invest. 70:1157–1169.CrossRefGoogle Scholar
  45. 45.
    Illingworth, D.R., N.A. Alam, E.E. Sundberg, F.C. Hagemenas and D.L. Layman. (1983). Regulation of low density lipoprotein receptors by plasma lipoproteins from patients with abetalipoproteinemia. Proc. Natl. Acad. Sci. USA 80:3475–3479.CrossRefGoogle Scholar
  46. 46.
    Sigurdsson, G., A. Nicoll and B. Lewis. (1977). Turnover of apolipoprotein B in two subjects with familial hypobetalipoproteinemia. Metabolism 26:25–31.PubMedCrossRefGoogle Scholar
  47. 47.
    Lim, C.T., J. Churag, H.J. Kayden and A.M. Scanu. (1976). Apoproteins of human serum high density lipoproteins. Isolation and characterization of the peptides of sephadex fraction V from normal subjects and patients with abetalipoproteinemia. Biochim. Biophys. Acta 420:332–341.Google Scholar
  48. 48.
    Gibson, J.C., A. Rubinstein, W.V. Brown, H.N. Ginsberg, H. Greten, R. Norum and H.J. Kayden. 1985. Apolipoprotein E containing lipoproteins in low density or high density lipoprotein-deficient states. Arteriosclerosis. In PressGoogle Scholar
  49. 49.
    Kayden, H.J. and M. Bessis. (1970). Morphology of normal erythrocyte and acanthocyte using nomarski optics and the scanning electron microscope. Blood 35:427–436.PubMedGoogle Scholar
  50. 50.
    Phillips, G.B. and J.T. Dodge. (1968). Phospholipid and phospholipid fatty acid and aldehyde composition of red cells of patients with abetalipoproteinemia. J. Lab. Clin. Med. 71:629–637.Google Scholar
  51. 51.
    Illingworth, D.R., D.K. Corbin, E.D. Kemp and E.J. Keenan. (1982). Hormone changes during the menstrual cycle in abetalipoproteinemia: Reduced luteal phase progesterone in a patient with homozygous hypobetalipoproteinemia. Proc. Natl. Acad. Sci. USA 79:6685–6689.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1986

Authors and Affiliations

  • Herbert J. Kayden
    • 1
  • Maret G. Traber
    • 1
  1. 1.Department of MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations